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Abstract: By reverse transcriptase-polymerase chain
reaction, enzyme-linked immunosorbent assay, and
immunohistochemistry, MGSA-a, -, -‘y, and CXCR2
mRNA expression and proteins are detected in 7 out
of 10 human melanoma lesions. The biological conse-
quence of constitutive expression of the MGSA/GRO
chemokine in immortalized melanocytes was tested in
SCID and nude mouse models. Continuous expression
of MGSA/GRO-a, -f’, or -‘y in immortalized melan-a
mouse melanocytes results in nearly 100% tumor for-
mation for each of the clones tested, whereas clones
expressing only the neomycin resistance vector form
tumors <10% of the time. Moreover, antibodies to the
M(;SA/GRO proteins slow or inhibit the formation of
tumors in the SCUD mouse model and block the an-
giogenic response to conditioned medium from the
tumor-producing clones. Transcription of the MGSA/
GR() chemokines is regulated by an enhancesome-
like complex comprised of the nuclear factor-KB (NF-
KB), HMG(l)Y, IUR, and Spi elements. In Hs294T
melanoma cells the half life of the 1KB protein is
shortened in comparison to normal retinal epithelial
cells, facilitating the endogenous nuclear localization
of N F-KB. We propose that this endogenous nuclear
NF-KB, working in concert with the 1 15-kDa IUR-
binding factor, promotes constitutive expression of
M(;sA/GR0 genes. J. Leukoc. Blot. 62: 588-597;
1997.
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INTRODUCTION
\Io-Ianotriia gno)\s’(hi stiniulaiitno’ ao’tivity’ (MGSA) otr gro)wth-
ro-gulato-d h)notto-iris (GRO) alotng with intenleukin-8, EN-
78. (( I-2. 1tlao-lo-t facton-4. 3-thromitoglobulin. platelet
I)asio- Itnto-i Ii. o-otnnecti’t tisstie activating factor, neutno-
Phuil activating to’ptio1o’-2 (JNP-2), rnig, inerferotn-y-
inducible pnttein-l0 (IF-b). and stromal-denived factor-
1 (SDF-1) comprise the CXC subfamily ofchemokines [1-
5]. There are three genes for MGSA/GRO that encode
closely related mRNAs and proteins. MGSA-a, -, and -‘y
[6-10]. Ro-ently, we have identified a fourth human
M(;SvGRO gene that is highly homologous but appears
(0) encode a pseudogene [1 1]. The structure for the MGSA/
GRO-a, -13 and -y genes includes four exons, separated
by three introns. which when spliced yield - 1.1 kb mR-
NAs (Fig. 1). The nucleotide sequences for these MGSA/
GRO-3 and -y genes show 93 and 82% identity to) MGSA/
GRO-a. respet-tively. The amino acid sequences for these
MGSA/GRO proteins are also highly (o)nserved. Of the 73
amino acids of the mature peptide, the MGSA/GRO-
pno)tein exhibits only seven amino) acid difkrences for
M(;SA/G RO-a and the MGSA/GRO-y protein exhibits
only nine amino) acid differences from MGSA/GRO-a. In
the mouso’, (wet homologs have been cloned, KC and mac-
nophage inflammatory protein-2 [9. 12], and in rat the
M(;SvcRo gene is named CINC [13]. Hamster, chicken,
pig, sheep, and rabbit homologs have also been o’haracter-
ized [1, 10, 14-16].
EXPRESSION OF MGSA/GRO-a, -3, -y
IN MELANOMA TUMORS
‘It) compare the expression of MGSA/GRO-a, -, -y
genes during the clinical course of metastatic melanoma,
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Fig. 1. Organization of the MGSA/GRO gene. The MGSA/GRO gene is organized into four exons (I through IN’) ine’rru1tted by three- introns.
The 5’ regulatory region is characterized by four (-is-acting elements that include binding seque’nces for the’ TAT binsding factors, NE-KIt, Spi.
and a novel demerit containing a TCGATC motif. 1”he arrow indicates the site of transcriptions initiation. The regken proximal to the’ transo-rip-
tion start site is highly conserved in a. , and y isofetrms o)f NIGSA/GRO. Significanit differences exist in the’ far upstro’ants (FUR) and the- 3’ on-
translated (3’ UTR) region of the three MGSA/GRO gene
we examined the mRNA distribution of these three gene
transcripts by reverse transcriptase-polymerase chain re-
action (RT-PCR) in 10 human melanoma cases. The RT-
PCR analysis detected all three MGSA/GRO mRNAs in 7
of 10 tumors, suggesting that all three MGSA/GRO genes
may be transcribed endogenously in melanoma tumor
cells (Table 1). By immunohistochemistry, we observed
the expression of MGSA/GRO-a and CXCR2 protein in 7
of 1 1 melanoma cases studied (Table 2 and Fig. 2) and
in some of the tumors there was co-expression of CXCR2
(Table 2 and Fig. 2). By enzyme-linked immunosorbent
assay the level of MGSA/GRO-a was considerably higher
than MGSA/GRO-’y in most of the tumors studied (Ta-
ble 1). The use of different portions of the tumor for
ELISA, RT-PCR, and IHC studies produced some van-
ability in the levels of MESA expression for these differ-
ent assays.
In contrast to the expression of MGSA/GRO proteins,
the angiogenesis inhibitory chemokine, IP1O, was barely
detectable in most of the melanoma lesions studied (Ta-
ble 2 and Fig. 2) though it is abundantly expressed in
normal skin. Thus a shift in the balance in expression of
stimulatory and inhibitory CXC chemokines could play a
part in the malignant progression of melanoma (umoni-
genesis, as has been suggested for notn-small-cell lung
cancer [17].
RECEPTORS FOR THE MGSA/GRO
CHEMOKINE
Four receptors for MGSA/GRO, interleukin-8 (IL-8), and
other ELR motif-containing CXC chemokines have been
described: CXCR2, the Herpesrirus samairi receptor ECRF3,
the Kaposi sarcoma human herpesvinus-8 G-pnotein-coupled
receptor, and the Dully antigen receptor for chemokines
[ref. 4 and ref. 18 (hr review]. The receptor Ion the MGSA/
GRO proteins is CXCR2, a seven-transmembrane G-pro-
tein-coupled receptor. CXCR2 hinds nott only MGSA/GRO,
but also IL-B, NAP-2, GCP-2, and ENA-78 [10]. CXCR2 is
present on neutrophils, basophils, lymphocytes, mono-
cytes, keratinocytes, endothelial cells, melanocyte-s. and
neurons [19-25]. Activation tf this receptor affects cell
migration as well as cell proliferation [10, 17, 24]. Recep-
ton activation includes coupling 0)1 the tnimo’nic G-protein
complex that activates PLC-, yrosinc kinases including









\IGSA-a MGSA- MGS-- CXCR2
1 0.015 0.0 - - - -
2 0.410 0.0 + - - -
3 0.005 0.0 - - - -
4 0.200 0.0 + + + +
5 10.888 0.0 + + + +
6 0.159 0.0 + + + +
7 1.457 0.0 + + + +
8 ND ND NE) NI) NI) NI)
9 0.132 0.241 + + + +
10 0.141 0.058 + + + +
11 0.199 0.304 + + + +
MGSA/GRO-a and MGSA/CRO-y were measured by KLISA and reported as nanograms of MGS per milligram of total protein from c-ads human nnelanoma
sample. Total RNA was extracted front melanoma tissues reverse transcription was performed usinsg ant equal amounst ol RN,N, thmens RT-PCR was 1ec-rfornsed using
the same 5’ primer 5’-GCAGACCGFGCAGGGAATFC-3’, and usinsg specific 3’ prinser for N1GSA/GRO-a s’-cuc:vF(;rruCA(;(;(:rccI’c,’-3’, her MGSA/GRO-(3
5’-ACCTCTCTGCFCTAACACNG-3’. and for NIGSA/GRO-y 5’-A(;GTGGCFGACACArFATGG-3’.
NI), not deternsiined: +. detectable: -. tint detectable.
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l’arallino-enmmhoecloleol tissue-s eore lortooosse-ol as iii Figeiro- 2 and ininitomnoostainie-d ‘esith eec-eilio anstileoeclv at time- chilemticcns described nm Figure- 6.
± . elighntlv ocositiso-: +. jooositiac: ++, nnmooclc-ralc-I ooositiao: +++. slrconmglv ioeositi%e: ++++. Very streengle jocositiac: t 1’. oconmneotiae tisue: K. c.I)iclerlitis F. hibroblasts:
I .. I’inmolmocovte-s: NI NI. nmmaligniant nne-lansccnnna: S NI. snmmeooctii niusole.
I I 30C\S. anti so’nino- kinases [3, 22. 26. 27]. M;\P-kinase
is tynosine photsphoenvlate-ol as a no-suit of this tascado- [28].
Liganoi I)inoiing tot CXCR2 activato’s a so-nino’ kinase that
phos1thotnvlatos the carbotxy-to-rminal oio)niain 0)1 (ho’ recep-
to)r itso-If, an ovont that negulato’s no-o-o-pton olo-so-nsitiza(ion
anti so-quo-stration [27]. Reo-uiitly’. (hit- sniall (-prttto’ins rae
anti rho havo bo-o’n sho%’n tot bo- invotlvo-ti in CXC ro’ceptor
tell niignatittn [2#{176})](Fig. 3). Our oltso-nvation that mela-
nouia tuti)ttn o-o-lls ant’ o’xpro’ssing iu)uiuno)ro’ao-tiv(- CXCR2
suggo-sts that thiono’ is a potential Ion an autoto-nino- lo)op such
that thio o-olls pnottluo-ing MGS/uRO l)rttt(’ins can also re-
sitoenti tot thiotso’ pntoins. ‘o- havo’ pno-viteusly no-potrto’d that
o-noiottho-lial co-Ils unoio-rgoing no-o)vaso-ulanizatiotn in human
l)unn %‘ounds o-xpno-ss immunono-at-tivo- CXCR2 [23]. How-
o’vo-n. otthens havo’ hati oliflicultv demotnstrating tho’ binding
of I l-8 ttt human vascular ondottliolial toils [30]. \\‘- have
otbsonvoti that the’ enol(tthio’lial oolls otf sonic otf the mi-
o-nttvo-sso-ls in tho- mo’lanonia tunions o-xpno-ss inhtnuno)reac-
(ivo’ CXCR2 (Tablo’s I anti 2. antI Fig. 2). This opens tho’
potssibility that the- MUSA/GRO o’xpression can positively
influonco- thio grotwthi of no’w blood vessels into he growing
tumotn anti proviolo- a continuous sounco’ of nutrients for
iiio’ tumo)r.
MOUSE MODEL TO TEST THE ROLE OF
MGSA/GRO PROTEINS IN MELANOCYTE
TUMORIGENESIS AND ANGIOGENESIS
ASSOCIATED WITH TUMOR GROWTH
1() det-rniino- tho- bittlcegio-al significance o)f de’no-gulation of
M(;SA/(; RO (-xpressio)n in melanocytes o-xpressing neco-p-
totrs for M(;S/(;RO, we o)verexpno’ssed MGS\/GRO-a. -3,
or -y in imniotrtalized motuse melanocytes. Continuotus cx-
pnessio)n otf any cent- oti these \IGSA/GRO protto-ins enables










Fig. 2. Irisnsunostaininsg e)f MGS\/GRO-a, CXCR2. and I P- I 0 in human tiselanionisa. Hunsiani niselanmeenima tunisors we’re oebtainie-el at time- tinnc cof
surgery with infeermed e-onso-nit ac-troling to) NIH guide-lines. Parafornsialdeyde’-lixed. paraffini-o-nmmbedded tissue- se-etionis we-re- e-xanmmine-ol feer chic--
mokino-s/ehensokinie rece’l)tor eXj)resSiorm l)y’ inoiirect insmiiunohistochso’mistre’ using \‘KC”FOR 1a1te)rateeries ELITE RC kit wlme-re- inimnimunmeedetec-
tion is visualized as a red or pink color. MGSA/GRO-a antibody [2 1] was used at a I : 100 dilution (pane-Is A-I)). CXCR2 anmtileetdy [2 1] I : I 000
diltmtioan (1tarse-ls K and F), and IP-lO antil)ody (a kind gift froni B. Stricter) I :500 dilution (pan-ls G aniel U). In the nsevus inivolved with trintna’
melanoma shown in case 8 (panels A. C, K. U), MGSA/GRO-a ans(i CXCR2 positive staining (red c-ulcer) cans ito- soon in tunamoer cells anid ntmicrove-s-
sels (as inelioa(ed by the arrow), hut I P-b staining (pinkish ro1 (.ole)r) is bare’Iy’ oletc’otahle. In ease 9 (pane-Is B. I ). F. H). tumeer cells arc stainse-el
strongly with NIGSA/GRO-a antibody. lightly’ with IP-lO antil)ody. and barely de’te-o-(al)lo- with CXCR2 antibooly. Its thse abse-nsee’ of primary’ anti-
body no positive signal was observed (data not shown).


















Fig. 3. Potential signal tranisdue-titns pathways
mediaeoi by CXCR2.
ntioio niit-o-, suggesting that tho’so- oo-lls o-xpress a recepto)n
for \IGSA/GRO proteins [3 1. 32]. The resultant pig-
rnento’oi tumons hiave a histology cttmpatihlo- with that
expecto-ol Ion mo’lanotma based on S100 and HMB45 stain-
ing [3 1 , 32]. MGSA/GRO proteins were pro)duced by the
nielano)uia o-o’lls in tho- tumo)r anti the cho’mokine could be
tic-to-ott-ti Isy immuno)histochemistny’. Whori tell o-ultures
went- o-stal)Iislio-oi from the umetns anti (lie’ ne-omycin-resis-
tant colonio-s wo’ro again sele-ted, tho’so- tells formed tu-
metns a socotnti timo- even more rapidly’ than with the initial
injo-t-tiotn. ‘Eho- tumtrs that fonmt-d we-re quite vascular. al-
though tutt as niuoh as those that fotrni in tho- B 16 mela-
nonia t-otntnols. Conditioned mo’dium frotni (ho’ MGSA/
CR0-a, -1. anti -y expressing clotnes wo-ro- examined for
ability (0) trot1itt- arigiogenesis with thio’ uso of the rat con-
nea mio-notpoto-ko-t assay [32]. Strong angiotgenic responses
wono- obso-nvo-ol fnttni conditioned mo’oliurn fnotrni clono’s ex-
pressing o-achi of the three MGSA/GRO proteins. Anti-
bO)tliOs tot the’ ro-spective M(;SA/(;RO chemokines. but
nott notnmal rabbit senum, blocko’d that angiogt’nio re-
sitonse [32] (Table 3).
‘he to-st who-tho-r he tumor grotwth ro’sulting in MGSA/
(; RO-o-xpno-ssing riio-lanocyles could be inhibited with anti-
bodies toe (ho- M(;SAI(;RO proteins. we- injo-cto-d SCII) mice
with melan-a o-lones otverexpnessing MG SAJG RO-a or
M(;SA/(;RO--- anti injected antibodies tot NIGSA/GRO-a.
antibotolie-s to) N1GSA/GRO-y, o)r no)rmal rabbit serum into
the initial to-Il inoculation sito every other olay otver a period
t)f two) and etne-haif months. We observed that the antibody
to MGSA/GRO-y markedly suppressed tumow growth for the
melan-a clones expressing MGSA/GRO-y arid only three of
the six mice formed tiny tumor-like nodules. In co)ntrast the
SCID mico’ carrying MGSAJGRO-’y-expnessing proteins in-
jected with normal rabbit serum rapidly formed large tumors.
Antibody to \‘IGSVGRO-a only partially reduced tumor for-
mation in the mice carrying MGSA/GRO-a expressing
melan-a clono-s (Table 4). The number of viablo- endothelial
cells in each tumor was determined by FACS analysis of Fac-
ton VIII positive cells. We are quantitating the number of en-
dothelial cells in the tumors arising in SCII) mit-c receiving
MGSAJGRO expressing melanocytes and injections of anti-
body to) MGSVGRO as compared to the cotn(rol group,
which received injections of normal nabbit serum. These data
demonstrate that the MGSA/GRO-a or MGSA/GRO-y ex-
pression in immtrtalized melanocytes cttntnibutes to tumor
growth by both autocnine and paracnine o’fficts. The auto-
cnine effects of MGSAJGRO promote the anchorage-
indepenolo-nt growth of the cells and (lit’ parat-nine effects
promoto’ the growth and migration of new hktod vo-ssels into
the (loweloping tumor. We predict that the neco’ptor involved
in these responses is CXCR2. Antibodies tot CXCR2 have
been shown tot slow the growth of a variety o)1 malignant mel-
anoma cell lint’s in vitro [33]. Although the me-lan-a cells
used in (ho’ assays described above express only low levels of
MGSAJGRO receptor based on ligand binding assays, appar-
ently these low levels of receptor are sufficio’nt tot transduce a
‘I’ABLE 3. Tumor Formation and Angi(ego-nio Re-spouse-s for MGSA/GRO-Expre-ssinsg \Ic-lanioec-yto-s
Loan et a!. MGSA/GRO in malignant melanoma tumor progression 593
\IGSA-e-x1rc-ssing
cell linse Tunior formation
Nudo nsio’e-
Cornsea angioge-nic-sis respoonisos
‘#{176}ithm consditionsed nmediunis \o ithi N 11S c\ tIn ohicnmmookinme-anmtilooodv
\Ie’l-a-b 6/6 6/6 5/6 0/8
yr14 7/9 (5/7 5/6 1/5
y:i12 9/9 NI) NI) NI)
‘it-37 9/9 NI) NI) NI)
1321#{176}) 9/9 4/f) 5/6 l/(
1325 9/9 3/6 NI) NI)
132-13 9/9 NI) NI) NI)
V-i 0/15 0/5 NI) NI)
V-4 0/6 NI) NI) NI)
V-6 2/6 2/6 NI) NI)
Hs2#{176})4T 5/5 NI) NI) NI)
‘Fhe N1;S/;Ro-a--xro’ssing cleanse (Mel-a-6). MGSA/GRO-13-o-xprc-ssing o’looncs (p2-5. f3- 13.  19). \IGS’/GRO---c-x1oro-ssinmg oloontos (‘y- I 2.  I 4. “y1-37).
ansd ve’oto)r ce)ntr(oI (lanes (\ - 1. \-4_ V-b) ss’ere insjc’ctc’d inte nude- nsicc-. ‘l’unssor toornsiations re-suIts are sho)wn. Ilydroons })e-Ile’ts oof sc-runmt-trc-o- otmlturo nno-chiutn oonioe-n-
trated Iroonn nmmoI-a-6. 3- I 9, y1_ 1 4. \‘ I . and \-4 we’re insplante’eI intoo time- rat ooornea as pre-oottsIy described [ I 7]. .‘nsgioogensic rospoonssos were slsoownt by \1(;SAI(;Ho-
expressing cleones 6 days later and angiogenic respenses wcre inslsil)ited by antibodie’s to respective N1(;SA/(;I1() prteitt but noot icy ntoornnal rabbit sorunii (NRS).
biological response that results in tumor formation. However,
we do no)t rule out the possibility that other proteins are also)
expressed in the MGSA/GRO overexpnessing immortalized
melanocytes, which may be induced secondarily and contnib-
ute to the transformation process. This hypothesis is cur-
rently under investigation. However, in the assays described
above, three different melan-a clones expressing the
neomycin resistance marker alone (vector control) were stud-
ied and of those controls only two tumors formed in 27 nude
mice injected (Table 3); in the SCID model, not tumors were
observed in the vector control group from the 12 mice in-
jected (Table 4). Therefore, we propose that overexpression
o)f MGSv(;RO proteins by immortalized melanocytes is a
positive elector of melanocyte tumor progression.
TRANSCRIPTIONAL DEREGULATION OF
MGSA/GRO GENE EXPRESSION
The transcriptional regulation of MGSA/GRO, lL-8, and
CXCR2 gene expression requires multiple transcription
factors. Sager’s laboratory was the first to demonstrate that
the nuclear factor-KB (NF-KB) o’lement is an esso’ntial reg-
ulator of MGSA/GRO gene transcription [34]. Matsusaka
et al. demonstrated that for lL-8. NE-KB wotrks in cotncent
with either C/EBP or AP-l to moolulato- the o-ytokine-
inducible transcription o)f lL-8 t3I. Sprengo-n o’t al. have
shown that CXCR2 expression is induced by tho’ cytokines,
granulocyte-macrophago’ -tlotny’-stimulating fat-totr anti IL-
2. and lipopolysacchanide can shonto-n the half life of he
mRINA for CXCR2 [361. We have ctnco-ntrato’d otun stuolies
on elucidation of the’ meohanism lo)r o-otnstitutivo’ o’xpnes-
sion of chemokines in malignant mo-lanotma tumor tells.
The lls294T hurnan nulanorna tell line o-xpnesses pni
manly M(;SA/GR0-a mRN\ endetgo’notusly, but MGSA/
GRO-3 an(l -y are induo-o’oi after lipotpolysacchaniolt’. IL-I,
or tumor necrosis factor a tre’atme-n(. Thie- constitutivo- cx-
pression of the \IGSA/GRO-a results in pant fnotm o’n-
hanced transcniptio)n in melariotma cells comparo-d with
normal retinal pigme’n o’pithelial colls (RPE) [37], anti in
part from enhanced stabilization ttf the mRIN fotr thus
gene [38]. \\e have shown that \i-K13 is no-quined fotn the
cy’tokine-induceol o’xpnession 0)1 \1GSA/GRO genes as wo’ll
as for the hasal/-orustitutivo’ expression of these go’nes. In
addition to) NlKB. Spi, HM((l)Y, and the immediato’ up-
stream regulaory (IUR) elo-ments/hinding factotrs are ne-
quired fotr the basal/constitulivo’ o-xpression of MGSA/
GRO [39. 40]. Baso-d on electromobility shift assay. (ho-nt’





Nb-ant ttmnnoor oolunito (tnt#{176})
ith NI3S \\ ith antibody ‘oNithi NIlS ithi antiloeod
Mel-a-fe 6/6 5/6 1 . I 0.7
Y:r14 b/() 3/6 0.6 0.1
N-i 0/6 - - -
\‘-4 0/6 - - -
‘Flie M(;S:/(;Ro-a-e’xpressing chonic (NIt-I-a-b). NIGSA/GRO-y-e-xpression c-lone (y5- 14). and vc-etor eocnstrcol ebonies (\ - I . \ -4) were inmjeoted insto S( 1I ) nmsice-.
K’e’- other olay these- nsiee received an insjections oof 500 .n.I. of antihcodie-s to the respcctivc \ICS./GRO prtc-in at the site ool nmelanmoecvtes injeoticont. and ooonmtreel
gro)ups receive-cl the sante course’ (01 insjectio)ns with 500 iL cof nornual ralobit se-ruin (NBS). Tunmor growths was lcolleowecl 1o ruler nsmeasurc-nmsc-nmt eel palpatalele- tunnoers.
At the tinie ol death, total tunnor volum was nsieasured by water (lisplace-ment and tartar \1 I I positive oells intiltrating tlse tomnmsoorssere o1uantitatc-d 1ev FLS analy-
sis as I)ro’iusIy described [17. 32. ‘l’he sample. size was six for 13 14 with \RS. onie bar y 14 witim armtiloo)eh trc-atmenst. live for nsc-l-a-6 \RS ans(1 anstileoely treat-
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I”ig. 4. I )oteotieonm of I t  B-I’. I l20)i’l’ nne-lanmecnmma nstmek-ar exrae-ts ve-re- e-xansiiimetl leer se-qtmo-nmee--spe-e-ific binsdinsg toe the- I t B clentmenmt. () I]eo-trte-
lmhmoenc.tio nmmeobility slmil’t assays (I NI S,\) ei(lm time- I I  B olenjieni slieos a sinsgle c-complex (arreew) that is eonipeted b exoess cef s ide t lee. omligeenmuc-le-
ceticle (\\ ‘I’-I t B) Ittit is tnnmafl’ectecl lee ani exccss eel time nmutanit (\I’I’-I t B) oligonitnoIeeetiele. (II) t N -cross linking anmaly sis b’ sceolitmnmmoleeeleo-yI sulfate-
ieeeI aer’cIannide ge-I eIeetroe1ehsc eresis (S I )S-I’N( l-) :  I 15-kI)a proete-in (arrems ) is eehsered as the nnaje)r o-rc:ess-linike-d 1)reedtltt. ‘rrcme I I re1trese-nmts
time I 35-kI )a. I ))ease I-tnnmcligestecl prceelcnet. A thmirel proeoluet (arrees I I I ) at - (5 kI )a c-ant alsee be seen. (C) Soetitiisesterni leloet anaI sis: F1s294T
muncIe-ar extracts ace-re- Iracticenmateol Icy S I)S-I#{176}.(; l. transsblotteoi tee nmc-nmnleranmcs. anmel prcel)e-el s ithi either the I I B cer time- nmutanmt I E 13 (\I’I’l t B) c-Ic-
llieltts. : I I .5k I )a ierc etc-i II iei nmcls to c t It- I I B elcnmmenmt lout no et tue NEFI t B eIcnmnenmt.
ant- not chuarugo-s in thn- I t B binoiing laoto)rs. Sp I . ten
H \l(;(l)’ in no-stoniso- tot (-vto)kino- stimulation in RPE colls
on Hs2#{176})4T mo-larionia (-0-115 [3#{176}),4()].
RAPID TURNOVER OF 1KB IN MELANOMA
CELLS IN ASSOCIATION WITH NUCLEAR
TRANSLOCATION OF NF-KB p65-p50
COMPLEX LEADS TO CONSTITUTIVE
EXPRESSION OF MGSA/GRO
s %st- vo-ro- so-art-hung tot unolo-nstanol tEst- mo-o-hanism by
% hit-h rno-lanotnia toils o-onstituivo-l’ o-xpno’ss \ltTS:/GRO-
‘I’ \Itl .1; 5. Stability eel IKI3 l#{176}reote-inmin I12#{176})(‘I’ anmol \RItE (ells
( :I IN I re-at lime-Itt
(nnminm)
I Kll lo- o-I. mt
Il2#{176})II’










I .c- cl. 0 ci IKII score nime-a’ure-el los \\ctcrnn lelcol anmaI si’. eel h1s2) II anmcl BPK
oloo.ooIio’extracts. Finc oIls ‘serc treated loor arinmg le-nmgthn. cl tilne sitlm e’teloo-
itc\ilniielo (0 l1\) .oc tlmat .taloiIitccl tIme Jcrootci11 inc tine- tisco oIl tjoc. o’ootmld 1)0
..tnioliooI. IKII ole-grade-s nmtooro raioiolI mo ntoornnmal \lth#{176}Ktells no ooonslnat too
I 1,20) Fl nmmo-lanooonmm.coeII. Stanselard clo iatic cnn. o 1 nll e iInic s c-re- ni time- ransge- el
± I0 (“a.
a,  ntto’tl that in the absent-c oti (-ytokino- tno-atnio-nt tho-re
is tro--1ennio’d Ro’l’ 1)65 and P50 cttrnplo-x in tho- nu(-leus otf
Hs2)4’l’ -olls baso’(i o)n o-lo-o-trophoretic r’no)b)ility shift assay
(FMSA) [38]. By \X’so-rn analysis, nuclo’i from (ho- lls294T
oolls oxhilti signifioantlv higher levels of Rel,’ t65 than
RPF tells. ‘lb disco-rn the mo-chuanism lotn this evo-rit, wo- o-x-
ariiino-d tlio’ t-ytotplasmio- lt-vo’ls 0)1 1KB in the t%’o to-Il lint-s
by’ \\esto’nn blot. IKIl pno)to-in levels went- marko-dly’ ltt%’er in
tho- o-y’tot})lasrll tel (hit’ I1s2#{176})4T cells cotmpaneoi with H
o-o-lls, which ooulti in turn It-ad to enhano-o-oi tnans1toent tef tluo
ao-tivo’ P6”P0 o-otm1)Iex tot (ho- nucleus. Howovo-n. (ho- inRN’
levo’ls fotr I KR s’o-no- uot oiiffo-rent in the ts’ot co’ll lint-s. ‘ibis
led us tot o-xaniino- tho’ half lift- of 1KB antI through thioso o-x-
poniments wo- lo-dnnu(i that (lie 1KB hualf lift’ is signilio-antly
shorter in tho- riio-lanoma co’ll line comparo’oi ‘ith tho- notti-
transfonnuo-ti RPI- tells (Table 5). Thus tho’ mo-lanotnia
turnor oo’lls havo- olo-vo-lo)petl a mechanism for napiol turnotver
0)1 lKh3. whit-h lo’aols tot an attivated nuclear NF-KU ootmplo-x.
s’hioh tan in turn induo-o- the co)nstitutivo- o’xpno-ssio)n otf
o-ho-mokiruo-s and otlio-r facteers that enal)lo- the o-o-lls to es-
0-apt- lnotm apt)pto)sis and bo-o-otme immortal.
CHARACTERIZATION OF THE IUR
BINDING FACTOR
,\t_ havo’ pnt-’iotusIy shotwn thua an enharut-o-n irnuio-diato’ly
upstro-am otl (lit- NF-Kfl o-lo-nient, the IL R, is alsot ro-oiuino-ol
for NIUSA/GRO tnanst-nip(io)n [391. \X’o- hiavo shotwn thiat
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Fig. 5. (,) l:\1s cef I )\: aflinitv c1sretnnatetgraphi Irartioenis. iis2e)I’F nuclear extracts %sere Iraetieenmatc-d cent Se-plmarose- ceenmjugatod iths nimtmtannt
I t’ B (\I’FI t B) ocr  iIel-tite I  B cleniienst \%itli unsocenjugatc-cl Se-lelmareese- as eoonitreol_ Beotiniel Iracticens e’cre’ bled s itim iliereasilng ecenmeenmtraticenis
of KCI. Fleos tlmrootmgli aniol eluates fronts all three, e-olunimns se-re- assas c-cl leer heinsdinig tee the I t H elemenit. I t B-F elnntes nm tIme 11)1) nit Ni KCI fraetieonm
tel the I I B ltut hoot t Iso Seleliare ese cleenme’ or tise \I’I’I t l3-Se-lelmar ese cc elti nminms. (13) Seetiths c-sterns Ide 1 anmal sis eel al Ii nmit fractie onms. Re eu nid anmel u nm-
i)eetlls(1 frae-tioenns freensm the- \l’l’-I t B and I 1 R-Seplsarceso c-oltmnnnts s c-re- Iraetieensated los’ S I)S-P:( i;. tranmsblcetted toe I#{176}\I )I’ nmmenimbranme. anmol prcelee.ol
%%‘itii eitiier time silel-t P I I. B eon tIle’ nititanit \I’FI I B clenimenits. I t B-s1ee-eilie ae-tivit. nnigratinmg at a relati e nsneelecnnlar .izc eel’ 1 1 5 kI )a. eltmtes in
the 1’O() ns\l KCl l’raotioenm eel tlse I t R-Se’phareose o-oltnnmin.
mutation tf hut’ ItJR within the context of a 5’-350-bp
lGS/(; RO-a/C’VF no’porten ct)ns(ruc( neoluto’s (lit- t-0)ns(i-
tutive expnessio)n of the CAT neponter in both Fls2#{176})4Tanti
RPE eils and significantly reduces the I L- I intiut-tion 0)1
CT a(-tivi(y in tho RPE cells [39]. \to)ro’o)vo-r. whit-n a
imal 2 x I Ii R re1Mtrten/CAT ce)nstnuct was tnansleo-to-oi into)
Hs294T iielanotma o)n RPE cells. it s’as o-apablo’ of pr1u1t
ing thuo’ tranlso-nil)tiorl 0)1 thue CAT ne-ponton [3o1. ‘iho’ no’-
cluineol nuolo-otide sequenco’ ion ltJ R binoling was ostalt-
lishied throtuglu E\ISA using a variety of mutants otf tho-
1U R as lttttontial o-onupetitors oil thuo’ lahelo-ol I t R Irotl)e
[:39]. \\ilu tho’se o’xpeniments we vero’ ablo’ tot o’stallish that
tho- so-quo-not- ‘I’CGTC is ossential Ion tho’ FMS by uso- of
Fig. 6. ‘I’ramsseriltieonsal r-gulation tof the-
\IGSA/U B() gene-. Peitative- Krihansoc--
osetnTic-. Fie (iSl(t i nig eleniienss Isa ye
bcenm identified ill time- \I(S:/(R() .5’ re-g-
ulater’e, ro-gieens.  nieedc-l fetr the- tranise-ril)-
tieenal re-gem Iatieonm eel lime ge-nc- inmoItneles ins-
teraeticoni cef I1el  anid I).e() stmbtnnsits
c)f N I-K 13 %ith cother ceensm 1et15ts eel ani
c_tm hmanmee-eeseonime- i nic)l\’i rig the ‘F’I’ Iteex.
II \1( (l) elouienit. ant S P 1 elc’nisenit. and a
nneve-l elenmsenit. I t B. eisieis tonitaitis a
‘I’CG1\’I’C nimeotif. :c1ditioontal factor(s) binsd-
hg ftmnilser tmlestro-anmm in time-s’ ne-goilateonv
ro-gieons usay alsoo play i nob- ins list- re-gtmla-
tieens tel \1(;S:/(; R genme e-xI)re-ssio)ns.
one-b-an extracts fnorii the- H lE anoi Hs2t)4’l’ o-o-lls 3#{176})j.By
ultraviolet-oross linking anti Southwo-sto-nn ltlott analysis
have’ do-nuonstrato-d that (ho- majoen protto-in Itirioling to tho- I t JR
is - 1 1 5 kI)a. with a uuiruotr ltanol anoturid 42 kI)a. ‘lb funthio’n
charao-to’nizo’ (ho’ Itnto-itis Itirioiing tot (lit- I ti R (I t R-F), s’e
rifled thio’ ILR-F fnotrn Hs294’F nut-loan o-xtrao-ts by affiriiy
churonuatognaphiy using a ruiultiruuenizo’d It R-oligoenut-lo-otido-
hound tot So’phanoeso-. ‘hit- I I 5-kl )a I t H-F oluto-ti at 0.4 \i
NaCI fnotnu this affinity ooluriin ariol totutnoel o-oelurnns P’
})ano-(1 sith niutant I t R otligotntio-loottiofe so-otie-no-o-s oiiol rutt
binti tho- I t R-F (Figs. 4 anti 5). \\e went’ ablo- tt oio-motn-
strate by’ l)ttth1 F \l S: arid Sotuthwo’sto’nn h)lttt that tho- I I 5-
kl)a pnttto-iri o-luto-s fnotrti (lit- o-o)lurnri at this pttsitittn. Con-
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tro)ls using niuarit ltIR in btth Southwestern blot anol
EMS olt-monstrato- that (ho’ binding of the 1 15-kDa pro-
tein is 5})(0ilic Ion the TCGATC seqttence.
Initial sequen(-o attempts on pre’parations of IUR-F
transblotto-ol tot PVI)F meiribnanes suggested that this pro-
(ciii is bloo-ketl at (ho’ amino) to’rminus. Therefore we turned
to an altennato- ap)roach 0)1 (ho’ tne hybrid screen using
the IUR as bait with prey o-loned from a eDNA expression
library she-ro- tho’ t-xpresso’d proteins were fused to the Gal-
4 ac(ivatio)n (lomain. Withu this system we identified several
IUR-F oandidato’ olones. The hUH element is found not
only in (ho- MGS1/GRO go’ne pnomo(er, but also in the
CXCR2 prttmt)(er. and in the promoters of several cytokines
and thuus is likely let ho’ a strategic regulator of transcription.
CONCLUDING REMARKS
In this revio-w, we- have- tietailed experiments that revealed
tho’ relativo’ fno’quo-ni-y til (ho- e-xpression of the MGSA/GRO
pro(o-ins and the CXCR2 ro!’oepton lo)n these chemokines in
hunuan mo’lanonua tunuotns, tho’ biologic-al significance ccl
co)ntinuous o’xpno-ssiotn t)f MGSA/GRO, and the mechanism
for endogenotus o’xpno’ssion of MGSA/GRO in melanoma
cells. Thus. oonditiotns lo’ading to) continuous expression of
ELR containing CXC chemokines can potentiate tumor
growth. This pto’ntiatin appears to involve both auto-
cnine c-fIeo-ts otn tho’ melanocytes and paracnine effects
on the endotthelial tells. The constitutive expression of
\I(;SA/(;Ro genes is regulated by at least four ransacti-
vating factors: NF-KB, HMG(l)Y. Spl. and the element im-
mediately upstream o)f he NF-KB element, the IUR (Fig. 6).
Hs294T malignant melanoma cells exhibit a rapid turn-
over otf the inhibitor otf nuclear NF-KB, known as I-KBa.
We ps(tilate that factons such as ultraviolet irradiation,
chnotnio inflammation, and chenuical carcinogens can lead
to) thue endogenous activation of kinases responsible for the
phuosphonylatio)n otf I-KB. As a result of this phosphoryla-
(ion. I-KB is degraded. NF-KB is translocated to the nu-
clous, and (ho’ resultant activated NF-KB works in concert
with the IUR, Spl. anti HMG(I)Y elements/binding factors
to Produco the constitutive expression of the MGSA/GRO
genes. This constitutive expression of chemokine in cells
that also express receptor for MGSA/GRO is associated
with tumorigenesis.
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